Cell-Free Fetal DNA Testing Market - Global Outlook and Forecast 2023-2027

Report ID: 830689 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Cell-Free Fetal DNA Testing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Cell-Free Fetal DNA Testing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Cell-Free Fetal DNA Testing Overall Market Size
    2.1 Global Cell-Free Fetal DNA Testing Market Size: 2021 VS 2027
    2.2 Global Cell-Free Fetal DNA Testing Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Cell-Free Fetal DNA Testing Players in Global Market
    3.2 Top Global Cell-Free Fetal DNA Testing Companies Ranked by Revenue
    3.3 Global Cell-Free Fetal DNA Testing Revenue by Companies
    3.4 Top 3 and Top 5 Cell-Free Fetal DNA Testing Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Cell-Free Fetal DNA Testing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Cell-Free Fetal DNA Testing Players in Global Market
        3.6.1 List of Global Tier 1 Cell-Free Fetal DNA Testing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Cell-Free Fetal DNA Testing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Cell-Free Fetal DNA Testing Market Size Markets, 2021 & 2027
        4.1.2 Abnormal Chromosome Number Detection
        4.1.3 Gender Testing
        4.1.4 Paternally Inherited Disorder Detection
        4.1.5 Paternity testing
        4.1.6 Others
    4.2 By Type - Global Cell-Free Fetal DNA Testing Revenue & Forecasts
        4.2.1 By Type - Global Cell-Free Fetal DNA Testing Revenue, 2016-2021
        4.2.2 By Type - Global Cell-Free Fetal DNA Testing Revenue, 2022-2027
        4.2.3 By Type - Global Cell-Free Fetal DNA Testing Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Cell-Free Fetal DNA Testing Market Size, 2021 & 2027
        5.1.2 Hospital
        5.1.3 Clinic Center
    5.2 By Application - Global Cell-Free Fetal DNA Testing Revenue & Forecasts
        5.2.1 By Application - Global Cell-Free Fetal DNA Testing Revenue, 2016-2021
        5.2.2 By Application - Global Cell-Free Fetal DNA Testing Revenue, 2022-2027
        5.2.3 By Application - Global Cell-Free Fetal DNA Testing Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Cell-Free Fetal DNA Testing Market Size, 2021 & 2027
    6.2 By Region - Global Cell-Free Fetal DNA Testing Revenue & Forecasts
        6.2.1 By Region - Global Cell-Free Fetal DNA Testing Revenue, 2016-2021
        6.2.2 By Region - Global Cell-Free Fetal DNA Testing Revenue, 2022-2027
        6.2.3 By Region - Global Cell-Free Fetal DNA Testing Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Cell-Free Fetal DNA Testing Revenue, 2016-2027
        6.3.2 US Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.3.3 Canada Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.3.4 Mexico Cell-Free Fetal DNA Testing Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Cell-Free Fetal DNA Testing Revenue, 2016-2027
        6.4.2 Germany Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.4.3 France Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.4.4 U.K. Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.4.5 Italy Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.4.6 Russia Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.4.7 Nordic Countries Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.4.8 Benelux Cell-Free Fetal DNA Testing Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Cell-Free Fetal DNA Testing Revenue, 2016-2027
        6.5.2 China Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.5.3 Japan Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.5.4 South Korea Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.5.5 Southeast Asia Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.5.6 India Cell-Free Fetal DNA Testing Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Cell-Free Fetal DNA Testing Revenue, 2016-2027
        6.6.2 Brazil Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.6.3 Argentina Cell-Free Fetal DNA Testing Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Cell-Free Fetal DNA Testing Revenue, 2016-2027
        6.7.2 Turkey Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.7.3 Israel Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.7.4 Saudi Arabia Cell-Free Fetal DNA Testing Market Size, 2016-2027
        6.7.5 UAE Cell-Free Fetal DNA Testing Market Size, 2016-2027
7 Players Profiles
    7.1 Sequenom Laboratories
        7.1.1 Sequenom Laboratories Corporate Summary
        7.1.2 Sequenom Laboratories Business Overview
        7.1.3 Sequenom Laboratories Cell-Free Fetal DNA Testing Major Product Offerings
        7.1.4 Sequenom Laboratories Cell-Free Fetal DNA Testing Revenue in Global (2016-2021)
        7.1.5 Sequenom Laboratories Key News
    7.2 Illumina, Inc.
        7.2.1 Illumina, Inc. Corporate Summary
        7.2.2 Illumina, Inc. Business Overview
        7.2.3 Illumina, Inc. Cell-Free Fetal DNA Testing Major Product Offerings
        7.2.4 Illumina, Inc. Cell-Free Fetal DNA Testing Revenue in Global (2016-2021)
        7.2.5 Illumina, Inc. Key News
    7.3 Ariosa Diagnostics
        7.3.1 Ariosa Diagnostics Corporate Summary
        7.3.2 Ariosa Diagnostics Business Overview
        7.3.3 Ariosa Diagnostics Cell-Free Fetal DNA Testing Major Product Offerings
        7.3.4 Ariosa Diagnostics Cell-Free Fetal DNA Testing Revenue in Global (2016-2021)
        7.3.5 Ariosa Diagnostics Key News
    7.4 Arup Laboratories
        7.4.1 Arup Laboratories Corporate Summary
        7.4.2 Arup Laboratories Business Overview
        7.4.3 Arup Laboratories Cell-Free Fetal DNA Testing Major Product Offerings
        7.4.4 Arup Laboratories Cell-Free Fetal DNA Testing Revenue in Global (2016-2021)
        7.4.5 Arup Laboratories Key News
    7.5 The Fetal Medicine Centre
        7.5.1 The Fetal Medicine Centre Corporate Summary
        7.5.2 The Fetal Medicine Centre Business Overview
        7.5.3 The Fetal Medicine Centre Cell-Free Fetal DNA Testing Major Product Offerings
        7.5.4 The Fetal Medicine Centre Cell-Free Fetal DNA Testing Revenue in Global (2016-2021)
        7.5.5 The Fetal Medicine Centre Key News
    7.6 Apollo Path labs
        7.6.1 Apollo Path labs Corporate Summary
        7.6.2 Apollo Path labs Business Overview
        7.6.3 Apollo Path labs Cell-Free Fetal DNA Testing Major Product Offerings
        7.6.4 Apollo Path labs Cell-Free Fetal DNA Testing Revenue in Global (2016-2021)
        7.6.5 Apollo Path labs Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Cell-Free Fetal DNA Testing Market Opportunities & Trends in Global Market
    Table 2. Cell-Free Fetal DNA Testing Market Drivers in Global Market
    Table 3. Cell-Free Fetal DNA Testing Market Restraints in Global Market
    Table 4. Key Players of Cell-Free Fetal DNA Testing in Global Market
    Table 5. Top Cell-Free Fetal DNA Testing Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global Cell-Free Fetal DNA Testing Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global Cell-Free Fetal DNA Testing Revenue Share by Companies, 2016-2021
    Table 8. Global Companies Cell-Free Fetal DNA Testing Product Type
    Table 9. List of Global Tier 1 Cell-Free Fetal DNA Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Cell-Free Fetal DNA Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Cell-Free Fetal DNA Testing Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - Cell-Free Fetal DNA Testing Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - Cell-Free Fetal DNA Testing Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - Cell-Free Fetal DNA Testing Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global Cell-Free Fetal DNA Testing Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global Cell-Free Fetal DNA Testing Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2022-2027
    Table 30. Sequenom Laboratories Corporate Summary
    Table 31. Sequenom Laboratories Cell-Free Fetal DNA Testing Product Offerings
    Table 32. Sequenom Laboratories Cell-Free Fetal DNA Testing Revenue (US$, Mn), (2016-2021)
    Table 33. Illumina, Inc. Corporate Summary
    Table 34. Illumina, Inc. Cell-Free Fetal DNA Testing Product Offerings
    Table 35. Illumina, Inc. Cell-Free Fetal DNA Testing Revenue (US$, Mn), (2016-2021)
    Table 36. Ariosa Diagnostics Corporate Summary
    Table 37. Ariosa Diagnostics Cell-Free Fetal DNA Testing Product Offerings
    Table 38. Ariosa Diagnostics Cell-Free Fetal DNA Testing Revenue (US$, Mn), (2016-2021)
    Table 39. Arup Laboratories Corporate Summary
    Table 40. Arup Laboratories Cell-Free Fetal DNA Testing Product Offerings
    Table 41. Arup Laboratories Cell-Free Fetal DNA Testing Revenue (US$, Mn), (2016-2021)
    Table 42. The Fetal Medicine Centre Corporate Summary
    Table 43. The Fetal Medicine Centre Cell-Free Fetal DNA Testing Product Offerings
    Table 44. The Fetal Medicine Centre Cell-Free Fetal DNA Testing Revenue (US$, Mn), (2016-2021)
    Table 45. Apollo Path labs Corporate Summary
    Table 46. Apollo Path labs Cell-Free Fetal DNA Testing Product Offerings
    Table 47. Apollo Path labs Cell-Free Fetal DNA Testing Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. Cell-Free Fetal DNA Testing Segment by Type
    Figure 2. Cell-Free Fetal DNA Testing Segment by Application
    Figure 3. Global Cell-Free Fetal DNA Testing Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Cell-Free Fetal DNA Testing Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Cell-Free Fetal DNA Testing Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Cell-Free Fetal DNA Testing Revenue in 2020
    Figure 8. By Type - Global Cell-Free Fetal DNA Testing Revenue Market Share, 2016-2027
    Figure 9. By Application - Global Cell-Free Fetal DNA Testing Revenue Market Share, 2016-2027
    Figure 10. By Region - Global Cell-Free Fetal DNA Testing Revenue Market Share, 2016-2027
    Figure 11. By Country - North America Cell-Free Fetal DNA Testing Revenue Market Share, 2016-2027
    Figure 12. US Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe Cell-Free Fetal DNA Testing Revenue Market Share, 2016-2027
    Figure 16. Germany Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 17. France Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia Cell-Free Fetal DNA Testing Revenue Market Share, 2016-2027
    Figure 24. China Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 28. India Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America Cell-Free Fetal DNA Testing Revenue Market Share, 2016-2027
    Figure 30. Brazil Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa Cell-Free Fetal DNA Testing Revenue Market Share, 2016-2027
    Figure 33. Turkey Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE Cell-Free Fetal DNA Testing Revenue, (US$, Mn), 2016-2027
    Figure 37. Sequenom Laboratories Cell-Free Fetal DNA Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Illumina, Inc. Cell-Free Fetal DNA Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. Ariosa Diagnostics Cell-Free Fetal DNA Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. Arup Laboratories Cell-Free Fetal DNA Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. The Fetal Medicine Centre Cell-Free Fetal DNA Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Cell-Free Fetal DNA Testing Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cell-Free Fetal DNA Testing Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cell-Free Fetal DNA Testing Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports